ClinicalTrials.Veeva

Menu

Serum Neuroglobin and Nogo-A Concentrations in Acute Traumatic Brain Injury

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Completed

Conditions

Traumatic Brain Injury

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Neuroglobin has been described as a marker of traumatic brain injury. Nogo-A plays an important role in mediating neuroanatomical plasticity and functional recovery following traumatic brain injury. The investigators sought to examine the changes in serum neuroglobin and Nogo-A concentrations in patients with traumatic brain injury during the initial 96-h posttraumatic period and assessed the relation of neuroglobin and Nogo-A to Glasgow Coma Score and prognosis of such patients with traumatic brain injury.

Enrollment

34 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who suffered head trauma and whose highest abbreviated injury score (AIS) was 3 or less (other than head injury)
  • Patients who delivered to hospital within 4 h

Exclusion criteria

  • Patients who suffered open injuries
  • Patients who had existing prior neurological disease
  • Patients whose serial serum samples could not be obtained
  • Patients less than 18 years of age
  • Patients who suffered severe life-threatening injury to organs other than the brain

Trial design

34 participants in 1 patient group

Traumatic brain injury
Description:
Patients delivered within 4 h whose highest abbreviated injury score (AIS) was 3 or less (other than head injury) were considered to be isolated traumatic brain injury cases and were included in this study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems